MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
Clinical trial NCT00482430 · COMPLETED
Trial details
- NCT number
- NCT00482430
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.